0001077183-19-000058.txt : 20190506 0001077183-19-000058.hdr.sgml : 20190506 20190506173154 ACCESSION NUMBER: 0001077183-19-000058 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190502 FILED AS OF DATE: 20190506 DATE AS OF CHANGE: 20190506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHOVLIN ROBERT J. CENTRAL INDEX KEY: 0001621453 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35756 FILM NUMBER: 19800508 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE CITY: FORT MYERS STATE: FL ZIP: 33913 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGENOMICS INC CENTRAL INDEX KEY: 0001077183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 742897368 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 BUSINESS PHONE: 9419231949 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC DATE OF NAME CHANGE: 19990120 4 1 wf-form4_155717829283180.xml FORM 4 X0306 4 2019-05-02 0 0001077183 NEOGENOMICS INC NEO 0001621453 SHOVLIN ROBERT J. 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 0 1 0 0 President, Clinical Services Common Stock 2019-05-02 4 M 0 66666 7.15 A 214987 D Common Stock 2019-05-02 4 M 0 66667 7.52 A 281654 D Common Stock 2019-05-02 4 S 0 52680 22.14 D 228974 D Common Stock 2019-05-02 4 S 0 66667 22.14 D 162307 D Stock Option (Right to Buy) 7.15 2019-05-02 4 M 0 66666 0 D 2017-04-20 2021-04-20 Common Stock 66666.0 0 D Stock Option (Right to Buy) 8.03 2019-02-26 2023-02-26 Common Stock 288500.0 288500 D Stock Option (Right to Buy) 7.52 2019-05-02 4 M 0 66667 0 D 2018-04-28 2022-04-28 Common Stock 66667.0 66667 D Stock Option (Right to Buy) 19.6 2020-03-01 2024-03-01 Common Stock 66897.0 66897 D On April 20, 2016, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date. On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. On March 1, 2019, Mr. Shovlin was granted an option to purchase 66,897 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date. /s/ Robert J. Shovlin 2019-05-06